Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 May 2024 | Story VALENTINO NDABA | Photo Supplied
Fun walk-run 2024
Step into fitness and fun at the UFS 5km Fun Run and Walk. Join us on 11 May at 6am at the Francois Retief Building, Bloemfontein Campus.

The heartbeat of the University of the Free State (UFS) is pulsing with excitement as the Faculty of Health Sciences gears up to host an event that promises to unite the campus and the Bloemfontein community in a celebration of health, vitality, and camaraderie as we mark Africa Month. Get your running shoes laced and your spirits high because on 11 May 2024, it’s time to join the free 5km Fun Run and Walk.

Date: 11 May 2024  
Time: 06:00  
Venue: Francois Retief Building, Bloemfontein Campus  

Why should you join?

Picture this: The crisp morning air filled with the rhythm of lively beats, the sun gently rising over the iconic Francois Retief Building, and a sea of smiling faces ready to embark on a journey of fitness and fun. The 5km fun run and walk is not just about breaking a sweat; it’s about fostering a sense of togetherness, promoting mental wellness, and embracing the joy of movement.

“Exercise should be fun. Most people believe that spending long hours exercising produces better results, whereas we want to encourage and show people that exercise should not feel like work – it should be fun,” says Jabulile Mabina, Assistant Officer at KovsieFit Gym.

Leading the charge in the fitness fiesta is KovsieFit, bringing its signature blend of energy and enthusiasm to the event. Mabina will guide participants through an invigorating aerobics session guaranteed to get those endorphins flowing and those muscles warmed up for the main event. Remember, exercise isn’t just about sculpting the body; it’s about nourishing the mind and soul too.

Community, connection, and compassion

At the heart of the fun run and walk lies a deeper purpose – to raise awareness about mental health and to foster a sense of community spirit as we celebrate Africa Month. Reuben Maeko, Senior Marketing and Communications Officer at the Faculty of Health Sciences, says: “The vision of the faculty of Health Sciences is to be research led and innovative, people centred, regionally engaged, and globally competitive. We prioritise the well-being of our students and staff by organising events that promote healthy lifestyles. Our focus is on our community, placing our people at the forefront of all our endeavours. Moreover, this event will underscore the importance of physical activity for students, keeping them active and healthy.”

This sentiment resonates with the theme for the 2024 Africa Month, which is World Citizenship and African Higher Education: Preparing Students for a Connected World.

Prizes galore

What’s a celebration without some rewards? Thanks to the generous support of sponsors like Standard Bank, Steers and Debonairs, Pimento, and Rhythm Finance, participants stand the chance to win an array of exciting prizes. Whether you’re a seasoned runner or a leisurely walker soaking in the sights, there’s something for everyone to look forward to.

Mark your calendars, spread the word, and lace up those running shoes because the UFS 5km Fun Run and Walk awaits. Whether you’re a staff member, a student, or a member of the Bloemfontein community, come join us as we step, stride, and smile our way to a healthier, happier tomorrow. Remember, it’s not just a run; it’s a journey of joy, unity, and well-being. See you at the starting line.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept